Logan Capital Management’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-9,909
| Closed | -$3.85M | – | 485 |
|
|
2025
Q2 | $3.85M | Sell |
9,909
-348
| -3% | -$140K | 0.18% | 130 |
|
|
2025
Q1 | $4.46M | Sell |
10,257
-465
| -4% | -$187K | 0.2% | 116 |
|
|
2024
Q4 | $3.96M | Sell |
10,722
-704
| -6% | -$295K | 0.17% | 131 |
|
|
2024
Q3 | $5.94M | Sell |
11,426
-805
| -7% | -$430K | 0.24% | 104 |
|
|
2024
Q2 | $6.63M | Sell |
12,231
-562
| -4% | -$297K | 0.29% | 94 |
|
|
2024
Q1 | $6.63M | Buy |
12,793
+104
| +0.8% | +$51.7K | 0.28% | 99 |
|
|
2023
Q4 | $5.98M | Sell |
12,689
-803
| -6% | -$371K | 0.28% | 99 |
|
|
2023
Q3 | $5.87M | Sell |
13,492
-1,037
| -7% | -$470K | 0.3% | 96 |
|
|
2023
Q2 | $6.46M | Sell |
14,529
-235
| -2% | -$108K | 0.31% | 88 |
|
|
2023
Q1 | $6.79M | Sell |
14,764
-104
| -0.7% | -$49.5K | 0.33% | 88 |
|
|
2022
Q4 | $7.63M | Buy |
14,868
+288
| +2% | +$146K | 0.39% | 79 |
|
|
2022
Q3 | $6.62M | Buy |
14,580
+1,773
| +14% | +$848K | 0.4% | 79 |
|
|
2022
Q2 | $6.18M | Buy |
12,807
+118
| +0.9% | +$58.4K | 0.36% | 83 |
|
|
2022
Q1 | $6.23M | Buy |
12,689
+179
| +1% | +$81.8K | 0.3% | 94 |
|
|
2021
Q4 | $5.8M | Sell |
12,510
-436
| -3% | -$183K | 0.25% | 106 |
|
|
2021
Q3 | $4.83M | Buy |
12,946
+743
| +6% | +$282K | 0.22% | 113 |
|
|
2021
Q2 | $4.66M | Buy |
12,203
+410
| +3% | +$157K | 0.22% | 112 |
|
|
2021
Q1 | $4.23M | Sell |
11,793
-418
| -3% | -$134K | 0.21% | 118 |
|
|
2020
Q4 | $3.92M | Sell |
12,211
-137
| -1% | -$42K | 0.2% | 116 |
|
|
2020
Q3 | $3.32M | Sell |
12,348
-439
| -3% | -$118K | 0.18% | 136 |
|
|
2020
Q2 | $3.36M | Buy |
12,787
+2
| +0% | +$534 | 0.19% | 115 |
|
|
2020
Q1 | $2.9M | Buy |
12,785
+2,707
| +27% | +$738K | 0.2% | 122 |
|
|
2019
Q4 | $3.04M | Buy |
10,078
+3,400
| +51% | +$936K | 0.17% | 130 |
|
|
2019
Q3 | $1.6M | Buy |
6,678
+176
| +3% | +$48.2K | 0.09% | 156 |
|
|
2019
Q2 | $1.83M | Buy |
6,502
+545
| +9% | +$149K | 0.11% | 145 |
|
|
2019
Q1 | $1.71M | Buy |
+5,957
| New | +$1.72M | 0.11% | 145 |
|
|
2016
Q2 | – | Sell |
-9,900
| Closed | -$1.38M | – | 271 |
|
|
2016
Q1 | $1.38M | Hold |
9,900
| – | – | 0.11% | 132 |
|
|
2015
Q4 | $1.38M | Sell |
9,900
-5,000
| -34% | -$689K | 0.11% | 130 |
|
|
2015
Q3 | $2.09M | Hold |
14,900
| – | – | 0.17% | 107 |
|
|
2015
Q2 | $2.45M | Hold |
14,900
| – | – | 0.18% | 108 |
|
|
2015
Q1 | $2.3M | Hold |
14,900
| – | – | 0.16% | 108 |
|
|
2014
Q4 | $1.87M | Hold |
14,900
| – | – | 0.14% | 118 |
|
|
2014
Q3 | $1.78M | Sell |
14,900
-2,000
| -12% | -$229K | 0.13% | 111 |
|
|
2014
Q2 | $1.82M | Hold |
16,900
| – | – | 0.13% | 108 |
|
|
2014
Q1 | $1.68M | Sell |
16,900
-1,500
| -8% | -$136K | 0.12% | 111 |
|
|
2013
Q4 | $1.7M | Hold |
18,400
| – | – | 0.12% | 117 |
|
|
2013
Q3 | $1.54M | Hold |
18,400
| – | – | 0.12% | 118 |
|
|
2013
Q2 | $1.17M | Buy |
+18,400
| New | +$1.38M | 0.09% | 133 |
|
Other funds holding ELV
Logan Capital Management's ELV Position: Q3 2025 in Review
Logan Capital Management sold out of Elevance Health (ELV) in Q3 2025, closing a stake of 9,909 shares — an estimated $3.85M sold.
Logan Capital Management first reported a position in ELV in Q2 2013 and held it in 38 quarters. The position peaked at $7.63M in Q4 2022. 1,510 funds tracked by Wall St. Rank hold ELV as of Q3 2025.
- Logan Capital Management reported no remaining Elevance Health position as of Q3 2025 after selling out during the quarter.
- Logan Capital Management sold 9,909 Elevance Health shares in Q3 2025, an estimated $3.85M.
- Logan Capital Management first reported a position in Elevance Health in Q2 2013 and held it in 38 quarters.
- Logan Capital Management's Elevance Health position peaked at $7.63M in Q4 2022.
- 1,510 funds tracked by Wall St. Rank held Elevance Health as of Q3 2025.
Based on Logan Capital Management's 13F filing for Q3 2025, filed 14 Nov 2025.